T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2018 Update

  • ID: 1945420
  • Company Profile
  • 40 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Becton Dickinson and Co
  • BioFire Diagnostics LLC
  • Celula Inc
  • Diadexus Inc
  • GenMark Diagnostics Inc
  • OpGen Inc
  • MORE
Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company’s products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company T2 Biosystems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Becton Dickinson and Co
  • BioFire Diagnostics LLC
  • Celula Inc
  • Diadexus Inc
  • GenMark Diagnostics Inc
  • OpGen Inc
  • MORE
T2 Biosystems Inc Company Overview
T2 Biosystems Inc Company Snapshot
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc – Pipeline Analysis Overview
T2 Biosystems Inc - Key Facts
T2 Biosystems Inc - Major Products and Services
T2 Biosystems Inc Pipeline Products by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc Pipeline Products Overview
Gram-Negative Resistance Panel
Gram-Negative Resistance Panel Product Overview
T2Dx - Antimicrobial Resistance
T2Dx - Antimicrobial Resistance Product Overview
T2Dx - Cancer
T2Dx - Cancer Product Overview
T2Dx - Cardiac
T2Dx - Cardiac Product Overview
T2Endotoxin
T2Endotoxin Product Overview
T2HemoStat
T2HemoStat Product Overview
T2Lyme Panel
T2Lyme Panel Product Overview
T2Lyme Panel Clinical Trial
T2MR Assay - Platelet Function Testing
T2MR Assay - Platelet Function Testing Product Overview
T2Plex
T2Plex Product Overview
T2 Biosystems Inc - Key Competitors
T2 Biosystems Inc - Key Employees
T2 Biosystems Inc - Key Employee Biographies
T2 Biosystems Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
T2 Biosystems Inc, Recent Developments
Jun 13, 2018: Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018
May 29, 2018: T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens
May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results
Mar 28, 2018: Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics
Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
Feb 09, 2018: Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing
Feb 05, 2018: T2 Biosystems Names John Sprague As CFO
Jan 04, 2018: T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel
Nov 20, 2017: T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017
Nov 09, 2017: T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017
Appendix
Methodology
About
Contact
Disclaimer

List of Tables
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
T2 Biosystems Inc Pipeline Products by Equipment Type
T2 Biosystems Inc Pipeline Products by Indication
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc, Key Facts
T2 Biosystems Inc, Major Products and Services
T2 Biosystems Inc Number of Pipeline Products by Development Stage
T2 Biosystems Inc Pipeline Products Summary by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
T2 Biosystems Inc Ongoing Clinical Trials Summary
Gram-Negative Resistance Panel - Product Status
Gram-Negative Resistance Panel - Product Description
T2Dx - Antimicrobial Resistance - Product Status
T2Dx - Antimicrobial Resistance - Product Description
T2Dx - Cancer - Product Status
T2Dx - Cancer - Product Description
T2Dx - Cardiac - Product Status
T2Dx - Cardiac - Product Description
T2Endotoxin - Product Status
T2Endotoxin - Product Description
T2HemoStat - Product Status
T2HemoStat - Product Description
T2Lyme Panel - Product Status
T2Lyme Panel - Product Description
T2Lyme Panel - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
T2MR Assay - Platelet Function Testing - Product Status
T2MR Assay - Platelet Function Testing - Product Description
T2Plex - Product Status
T2Plex - Product Description
T2 Biosystems Inc, Key Employees
T2 Biosystems Inc, Key Employee Biographies
T2 Biosystems Inc, Other Locations
Glossary

List of Figures
T2 Biosystems Inc Pipeline Products by Equipment Type
T2 Biosystems Inc Pipeline Products by Development Stage
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • OpGen Inc
  • GenMark Diagnostics Inc
  • Celula Inc
  • BioFire Diagnostics LLC
  • Diadexus Inc
  • Becton Dickinson and Co
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll